James Hambro & Partners
- SEC CIK
- 0001731152
- Latest filing
- Jul 23, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,324
- Value
- $1.59M
- % of portfolio
- 0.1%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,324 | $1.59M | 0.1% | +878+196.9% | Added | Holders |
| Q1 2026 | 446 | $410.4K | <0.1% | +144+47.7% | Added | Holders |
| Q4 2025 | 302 | $324.6K | <0.1% | −41−12.0% | Reduced | Holders |
| Q3 2025 | 343 | $261.5K | <0.1% | +15+4.6% | Added | Holders |
| Q2 2025 | 328 | $255.5K | <0.1% | −12−3.5% | Reduced | Holders |
| Q1 2025 | 340 | $280.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 340 | $262.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 340 | $301.0K | <0.1% | +12+3.7% | Added | Holders |
| Q2 2024 | 328 | $297.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 328 | $254.9K | <0.1% | +328 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −1,828−100.0% | Sold out | Holders |
| Q3 2021 | 1,828 | $422.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,828 | $419.0K | <0.1% | −100−5.2% | Reduced | Holders |
| Q1 2021 | 1,928 | $360.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.